Knowridge5d
First new treatment for asthma and COPD in half a century – new study
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Hosted on MSN1mon
Patient perspectives central for developing new therapies for COPD
"The development of a unified set of patient-inspired health concepts in COPD is aligned with the U.S. Food and Drug Administration Patient-Focused Drug Development guidance series and establishes ...
pharmaphorum1d
GSK says Nucala hits the target in new COPD trial
The drug remains one of GSK's top products, with sales of £856 million ($1.1 billion) in the first half of this year, up 15%. COPD could open up a massive new market for the drug, which still has ...
Hosted on MSN1mon
FDA to review GSK’s Nucala for COPD
The study involved 804 COPD patients exhibiting type ... The Prescription Drug User Fee Act (PDUFA) date for the potential new indication is 7 May 2025. In November 2024, the European Commission ...
pharmaphorum9d
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process. ICER isn't officially involved in the price negotiations introduced ...